Sino Biopharmaceutical's TQB2868 Approved for Phase III Trial in Metastatic Pancreatic Cancer
CompanyDrug

Sino Biopharmaceutical’s TQB2868 Approved for Phase III Trial in Metastatic Pancreatic Cancer

Ocumension Therapeutics Gains CDE Approval for Phase III Presbyopia Trial
CompanyDrug

Ocumension Therapeutics Gains CDE Approval for Phase III Presbyopia Trial

Jiangxi Rimag Plans Acquisition of Changsha Zhongya Medical for RMB 29.5 Million
CompanyDeals

Jiangxi Rimag Plans Acquisition of Changsha Zhongya Medical for RMB 29.5 Million

Biogen Launches Qalsody in China for SOD1-ALS Treatment
CompanyDrug

Biogen Launches Qalsody in China for SOD1-ALS Treatment

Boehringer Ingelheim and Echosens Expand Partnership to Tackle MASH
CompanyDeals

Boehringer Ingelheim and Echosens Expand Partnership to Tackle MASH

China Expands Medical Insurance Coverage in New State Council Guidelines
Others

China Expands Medical Insurance Coverage in New State Council Guidelines

WuXi Biologics Commences Construction on Microbial Production Base in Chengdu
Company

WuXi Biologics Commences Construction on Microbial Production Base in Chengdu

Sihuan Pharma's Xuanyuening Granted New Indication Review in China
CompanyDrug

Sihuan Pharma’s Xuanyuening Granted New Indication Review in China

Johnson & Johnson Launches Tremfya IV in China for Inflammatory Bowel Diseases
CompanyDrug

Johnson & Johnson Launches Tremfya IV in China for Inflammatory Bowel Diseases

"Deep Surgery Secures Pre-Series A Funding for Microsurgery Robot Expansion
CompanyDeals

Deep Surgery Secures Pre-Series A Funding for Microsurgery Robot Expansion

ImmuneOnco Appoints Zhuli Wu as Chief Medical Officer to Lead Clinical Strategy
Company

ImmuneOnco Appoints Zhuli Wu as Chief Medical Officer to Lead Clinical Strategy

Hengrui Pharmaceuticals Launches Aiweida for HER2-Mutated NSCLC in China
CompanyDrug

Hengrui Pharmaceuticals Launches Aiweida for HER2-Mutated NSCLC in China